Previous Close | 0.0650 |
Open | 0.0000 |
Bid | 0.0600 x N/A |
Ask | 0.0650 x N/A |
Day's Range | 0.0000 - 0.0000 |
52 Week Range | |
Volume | |
Avg. Volume | 29,696 |
Market Cap | 5.051M |
Beta (5Y Monthly) | 1.15 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3400 |
Earnings Date | Aug 23, 2023 - Aug 28, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CLS Holdings USA Inc., and Oasis Cannabis Dispensary are pleased to welcome The Real McCoy to our Dispensary shelves.
"On an absolutely beautiful April 20th in Las Vegas, Nevada, Oasis Cannabis Dispensary saw 2,700 people who spent an average of $70 per person.
CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), (the ''Company'' or ''CLS''), a diversified cannabis company operating as Cannabis Life Sciences, today announced its financial results for the fiscal quarter ended February 28, 2023 ("Q3 2023"). All amounts are expressed in U.S.
CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), (the ''Company'' or ''CLS''),a diversified cannabis company operating as Cannabis Life Sciences, announced today that the company's wholesale manufacturing division, City Trees, is again ranked as the number one concentrate brand by units sold in Nevada.
CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), (the ''Company'' or ''CLS''), a diversified cannabis company operating as Cannabis Life Sciences, today announced its financial results for the fiscal quarter ended August 31, 2022 ("Q1 2023"). All amounts are expressed in U.S.
LAS VEGAS, NV / ACCESSWURE / September 15, 2022 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, today announced that following receipt of the requisite approval of debenture holders and the Canadian Securities Exchange, it has amended the terms of its outstanding US$13,219,150 principal amount unsecured convertible debentures (the "December Debentures")
CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the "Company" or "CLS", a diversified cannabis company operating as Cannabis Life Sciences, today announced the resignation of CEO and Chairman Jeff Binder, as well as the subsequent appointment of Andrew Glashow as CEO, and the addition of a new member to the Board of Directors, David Zelinger.
CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating as Cannabis Life Sciences, today announced that a meeting (the "Meeting") of holders (the "Debentureholders") of the 8.0% unsecured convertible debentures due December 12, 2022 (the "Debentures") of CLS USA, Inc. issued pursuant to an indenture dated as of December 12, 2018, as amended pursuant to a supplemental indenture dated as of March 31, 2021 (as the same has otherwise bee
LAS VEGAS, NV / ACCESSWIRE / July 12, 2022 / In an industry dominated by multi-state operators (MSOs), it takes a lot for a local independent name to gain significant brand recognition, let alone reach a number one status above the rest. But when consistent, quality products meet an honest, culture- and education-driven operation, it's no surprise that consumers flock to the small fish in a sea of giants.